# Dienogest

## Visanne 2mg

| TAH Drug Code      | [OVIS2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OVIS2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Management of pelvic pain associated with endometriosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | 1 tablet once daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Visanne should not be used in patients with any of the following conditions (some information is derived from other progestin-only formulations). If any of the following conditions occur during Visanne treatment， the medication must be discontinued immediately: ‧ Active venous thromboembolism ‧ Current or past history of arterial and cardiovascular disease (e.g.， myocardial infarction， stroke， ischemic heart disease) ‧ Diabetes mellitus with vascular complications ‧ Current or past severe liver disease with unresolved abnormal liver function values ‧ Current or past liver tumors (benign or malignant) ‧ Known or suspected hormone-dependent malignant tumors ‧ Undiagnosed vaginal bleeding ‧ Hypersensitivity to the active ingredient or any excipients in this product                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | 1% to 10%: Central nervous system: Headache (7%)， depression (3%)， disturbed sleep (2%)， irritability (1%)， migraine (1%)， nervousness (1%) Dermatologic: Acne vulgaris (2%)， alopecia (1%) Endocrine & metabolic: Breast changes (discomfort: 5%)， weight gain (4%)， ovarian cyst (3%)， decreased libido (2%) Gastrointestinal: Nausea (4%)， abdominal pain (2%) Genitourinary: Vaginal hemorrhage (1%) Neuromuscular & skeletal: Weakness (2%) <1%， postmarketing， and/or case reports: Abdominal distress， anemia， anxiety， back pain， breast induration， constipation， decreased glucose tolerance， dermatitis， diarrhea， disturbance in attention， dysautonomia， edema， feeling of heaviness (extremities)， fibrocystic breast disease， flatulence， genital discharge， GI inflammation， hot flash， increased appetite， limb pain， lump in breast， mood changes， muscle spasm， onychoclasis， ostealgia， palpitations， pelvic pain， pruritus， skin pigmentation， skin photosensitivity， tinnitus， urinary tract infection， vulvovaginal candidiasis， vomiting， vulvar dryness， xeroderma， xerophthalmia. |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/dienogest-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

